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Background: Swedish Cystic Fibrosis (CF) care follows international guidelines
in general. However, individually tailored moderate intense physical handling in
infants and thereafter physical exercise has been the primary base for the airway
clearance therapy for >25 years. The aims of this study were to describe the Peak
Working Capacity (PWC) in a Swedish multi CF centre population, especially in
the subgroup with substantially impaired lung function, and to evaluate PWC rate
of change over a three year period.
Methods: Simultaneous measurements of PWC and FEV1 were collected from
medical records and presented as % of predicted (%p) in all patients at three national
CF centres, comprising 74% of all Swedish CF patients. All patients independent of
age had been equipped with individually tailored and frequently optimized treatment
programs including physical exercise since 1984 or the day of diagnosis.
Results: Of all 205 eligible CF patients 7 years old 191 (93%) were included.
Mean age was 20 (range 7−60) years. Mean (SD) FEV1 was 77(25) %p and PWC
100(26) %p (females 105 and males 94%p). Individuals with FEV1 50 %p showed
mean PWC 75(23) %p. Mean annual rate of change of PWC %p was −1.0(6.6),
p = 0.071. Annual rate of change was dependent on annual FEV1 %p rate of change,
p< 0.0001, but independent of age, and of FEV1 %p at start, p = 0.395.
Conclusion: PWC can be well maintained over time in CF patients, even if lung
function is substantially impaired. A CF care package with a physiotherapy regimen
including physical exercise from the day of diagnosis could possibly explain these
results.
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Regular assessment of exercise capacity in CF is a useful tool to aid exercise pre-
scription and monitor changes in disease state. In particular, aerobic tests measuring
peak exercise capacity and sub-maximal exercise responses are especially useful in
highlighting changes in aerobic ﬁtness, functional ability and any subsequent impact
on quality of life. We aimed to assess which exercise tests, if any, are used in UK
CF centres.
We surveyed 40 UK centres (19 adult, 21 paediatric) units using a structured ques-
tionnaire asking about the timing and use of exercise testing for their CF patients.
Only 35 centres (88%) routinely measured exercise capacity in their patients. Peak
exercise capacity (VO2 Peak) was measured in 32 (91%) and sub-maximal or steady
state exercise capacity (VO2 MSS) in 21 (60%), with 13 centres (37%) using both
tests. Of those centres measuring peak exercise, patients were assessed via a shuttle
test in 20 (63%), the Chester step test in 7 (22%) and via cycle ergometer in 5
(16%). Sub-maximal values were assessed via a 6-min walk in 13 (62%) centres,
YMCA 3-min step test in 5 (24%), treadmill in 2 (10%) and cycle ergometer in 1
(5%). As regards timing, 28 centres (80%) assessed exercise capacity routinely at
annual review (14 of these at no other time), 15 (43%) routinely during an inpatient
stay, 10 (29%) due to clinical need and 7 (20%) prior to exercise prescription.
Standardised tests to assess exercise capacity in CF patients would improve inter-
centre communication, especially during transition. We are now designing a study
to ascertain which of these tests best measures exercise capacity in our patients.
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Peak work capacity (PWC%) (corrected for lung function) measures physiological
reserve and can be used to estimate the patient’s ﬁtness, which in turn may reﬂect
the burden they place on healthcare resource use. Currently, the most commonly
used prognostic indicator in CF patients is the FEV1, which is inversely related
to treatment burden and healthcare utilisation. We have compared the relationship
between PWC%, FEV1, and healthcare resource utilisation in a group of 75 adult
CF patients (mean age 27 years [range 20−48], 45 males) attending our large adult
clinic.
PWC% (measured during a phase of clinical stability) was correlated with the best
FEV1 (% predicted over the preceding year), inpatient days, and length of stay and
outpatient visits over a 4 year period. Kendall’s rank correlation was used to analyse
the association between these variables.
Although PWC% correlated concordantly with FEV1 (p< 0.001), it had a stronger
correlation than FEV1 with the number of admissions (0.0008 v 0.004), inpatients
days (0.0005 v 0.007), and outpatient attendances (0.02 v 0.10) respectively.
Thus study shows that Peak Work Capacity is a sensitive indicator of healthcare
resource utilization in CF patients, and its measurement should be used more
routinely in CF centers. It may prove to be a useful adjunct to the currently available
prognostic indicators in this increasingly common chronic condition.
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Introduction: There is limited research on the use of exercise tests outside the
clinical laboratory setting in children with CF.
Aims: To assess reliability and acceptability of (a) cycle ergometry tests, and
(b) using the LifeShirt to record cardiorespiratory responses during cycle ergometry
tests, in children with CF.
Methods: Children with CF and stable lung disease wore the LifeShirt during
2 cycle ergometry tests (intermittent sprint test (IST) measuring muscle power;
continuous incremental test (CIT) measuring cardiorespiratory ﬁtness) on 2 occa-
sions 7−8 days apart. Acceptability data were collected by questionnaire.
Results: 10 children with CF completed the study: (5M:5F), 9(2) y, FEV1: 83(14)%.
Peak power (IST) and peak work capacity (CIT) were reliable (bias p> 0.05,
CV< 10%). Tidal volume, ventilation, respiratory rate, fractional inspiratory time,
heart rate and SpO2 recorded by the LifeShirt demonstrated no signiﬁcant bias
(p> 0.05). Respiratory rate, fractional inspiratory time, heart rate and SpO2
demonstrated acceptable CVs (<10%). Acceptability questions indicated that cycle
ergometer tests and the LifeShirt were mainly acceptable to the children.
Conclusion: This is the ﬁrst study to report reliability of cycle ergometry in children
with CF. The LifeShirt may be useful for simultaneous measurement of respiratory
rate, fractional inspiratory time, heart rate and SpO2 outside the normal clinical
laboratory setting, however, there is concern over volume components of breathing
in children with CF.
